Researchers identified gut microbiome markers that predict melanoma return after surgery, allowing doctors to personalize immunotherapy for patients.

Yerkes described this period not as a recovery, but as a navigation of a "new normal." For many survivors, the mirror becomes ...

Repeated periocular and facial irradiation contributes to lasting cosmetic and functional changes that can intensify distress ...

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III ...

The National Ovarian Cancer Coalition (NOCC) delivers free meals to ovarian cancer patients, easing treatment burdens and ...

Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms ...

Your study found that analyzing specific bacterial groups in the in the gut could predict melanoma recurrence with a very ...

Cancer care is not experienced equally across the globe. Speaking at the 2026 NCCN Annual Conference, Caroline Taylor, ...

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with ...

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite ...

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.